Neuropathology of drug addictions and substance misuse. Volume 2, Stimulants, club and dissociative drugs, hallucinogens, steroids, inhalants, and international aspects

Content: 
Front Matter,Copyright,List of Contributors,Preface,AcknowledgmentsEntitled to full textPart I: StimulantsSection A: General AspectsChapter 1 - Cocaine: Usage, Misuse, and Addiction Processes. An Overview, Pages 5-13, Derek P. Simon, Mary Jeanne Kreek
Chapter 2 - Amphetamine Usage, Misuse, and Addiction Processes: An Overview, Pages 14-24, Nicola Simola, Manolo Carta
Chapter 3 - Mephedrone: An Overview of Its Neurotoxic Potential, Pages 25-35, Mariana Angoa-Pérez, Donald M. Kuhn
Chapter 4 - Cocaine and Brain-Derived Neurotrophic Factor, Pages 39-47, Lisia von Diemen, Giovana Brolese, Marianne Possa, Silvia Bassani Schuch, Anne Orgler Sordi
Chapter 5 - On the Role of the Endocannabinoid System in Cocaine Addiction, Pages 48-62, Przemysław Adamczyk, Mariusz Papp
Chapter 6 - The Fas Receptor/Fas-Associated Protein and Cocaine, Pages 63-73, M. Julia García-Fuster, María Álvaro-Bartolomé, Jesús A. García-Sevilla
Chapter 7 - Cocaine and Neuromolecular Imaging of Neurotransmitters in the Brain: BRODERICK PROBE® Laurate Nanobiosensors in Mesocorticolimbic Neurons and the Nucleus Accumbens: Sex and Genes, Pages 74-85, Patricia A. Broderick
Chapter 8 - Metabotropic Glutamate 5 Modulators: Potential Agents for Treating Cocaine Addiction, Pages 86-96, Christina J. Perry, Andrew J. Lawrence
Chapter 9 - Neuronal and Behavioral Effects of Amphetamine in Caenorhabditis elegans, Pages 97-107, Lucia Carvelli
Chapter 10 - Amphetamines Activate G-Protein Coupled Trace Amine-Associated Receptor 1 (TAAR1): Implications for Understanding and Treating Psychostimulant Abuse, Pages 108-116, David K. Grandy
Chapter 11 - Amphetamine and Signal Detection, Pages 117-125, Matthew E. Andrzejewski, Nicole Holder
Chapter 12 - The Effects of Amphetamine and Methamphetamine on Brain Activity-Related Immediate Early Gene Expression, Pages 126-136, Peter R. Kufahl, Elisabeth Moore, M. Foster Olive
Chapter 13 - Methamphetamine-Induced Behavioral Abnormalities and Neuronal Apoptosis, Pages 137-146, Tomohiro Abekawa
Chapter 14 - Methamphetamine and the JAK/STAT Pathway, Pages 147-154, Joana Gonçalves, Ana Paula Silva
Chapter 15 - Methamphetamine and the Blood–Brain Barrier, Pages 155-168, Ricardo Alexandre Leitão, Vanessa Coelho-Santos, Ana Paula Silva
Chapter 16 - Melatonin Receptors as Modulators of Methamphetamine-Mediated Behaviors, Pages 169-180, Shannon J. Clough, Anthony J. Hutchinson, Margarita L. Dubocovich
Chapter 17 - Methamphetamine Neurotoxicity and the Ubiquitin–Proteasome System, Pages 181-188, Anna Moszczynska
Chapter 18 - Methamphetamine and Neuronal Nitric Oxide, Pages 189-195, Chitra D. Mandyam
Chapter 19 - Candidate Genes of Chromosome 18q21, Methamphetamine, and Psychosis, Pages 196-205, Byung Dae Lee
Chapter 20 - Structural and Functional Aspects of Stimulant Misuse and Addiction, Pages 209-219, Alfonso Barrós-Loscertales
Chapter 21 - Sleep and Cocaine, Pages 220-228, Gustavo A. Angarita, Sofija V. Canavan, Sarah E. Hodges, Peter T. Morgan
Chapter 22 - Motivations for Use of Crack Cocaine, Pages 229-236, Alissa M. Greer, Gina Martin, Chantele Joordens, Scott Macdonald
Chapter 23 - Cocaine and Postmortem Levels in Neurological Tissues, Pages 237-244, Eduardo Alvear Serrano, Dietrich von Baer, Claudia Mardones, Carola Vergara Rosales
Chapter 24 - Cerebral Gray Matter Volumes in Cocaine Dependence: Clinical and Functional Implications, Pages 245-256, Chiang-Shan R. Li
Chapter 25 - The Rise of the Ego: Social Cognition and Interaction in Cocaine Users, Pages 257-268, Boris B. Quednow
Chapter 26 - Amphetamine-Induced Psychosis, Pages 269-280, Vahid Farnia, Senobar Golshani
Chapter 27 - The Role of Environmental Context in Amphetamine Abuse, Pages 281-291, Daniela F. Fukushiro, Laís F. Berro, Renan Santos-Baldaia, André W. Hollais, Raphael Wuo-Silva
Chapter 28 - Adolescent Exposure to Amphetamines and Vulnerability to Addiction, Pages 292-299, Emily R. Hankosky, Joshua M. Gulley
Chapter 29 - The Effect of Oxytocin on Methamphetamine Addiction, Pages 300-308, Chun-Fu Wu, Jing-Yu Yang, Fang Wang
Chapter 30 - Peripheral Influences of Methamphetamine Neurotoxicity, Pages 309-319, Amanda L. Blaker, Nicole A. Northrop, Bryan K. Yamamoto
Chapter 31 - Methamphetamine-Induced Hyperlocomotion: A Focus on the Role of the Prefrontal Serotonergic System, Pages 320-328, Yukio Ago, Kazuhiro Takuma, Toshio Matsuda
Chapter 32 - 1H-Magnetic Resonance Spectroscopy and Methamphetamine, Pages 329-335, Fleur Margaret Howells
Chapter 33 - Neuropsychological Aspects of Methamphetamine Use Disorders and Human Immunodeficiency Virus Disease, Pages 336-345, Erin E. Morgan, Jennifer E. Iudicello, Erica Weber, Steven Paul Woods
Chapter 34 - Quantitative Colorimetric Assays for Methamphetamine, Pages 349-359, Aree Choodum, Niamh NicDaeid
Chapter 35 - Assays for Methamphetamine and Amphetamine in Blood, Pages 360-374, Takeshi Kumazawa
Chapter 36 - Gamma-Hydroxybutyrate Abuse and Dependence, Pages 379-387, Martijn van Noorden, Rama Kamal, Boukje Dijkstra, T.M. Brunt, Cor de Jong
Chapter 37 - Effects of Club Drugs on Dopaminergic and Serotonergic Systems: Use of [18F]FDOPA, [99mTc]TRODAT-1, and [I∗]ADAM, Pages 391-405, Skye Hsin-Hsien Yeh, Chun-Kai Fang, Jeng-Jong Hwang
Chapter 38 - MDMA and Glutamate: Implications for Hippocampal Neurotoxicity, Pages 406-414, John H. Anneken, Stuart A. Collins, Bryan K. Yamamoto, Gary A. Gudelsky
Chapter 39 - MDMA (Ecstasy) and Gene Expression in the Brain: An Overview of Microarray and Candidate Gene Studies Assessing Transcriptional Changes in Rodents, Pages 415-430, Noelia Fernàndez-Castillo, Marta Ribasés, Bru Cormand
Chapter 40 - Mitochondrial Trails in the Neurotoxic Mechanisms of MDMA, Pages 431-444, Daniel José Barbosa, João Paulo Capela, Maria de Lourdes Bastos, Félix Carvalho
Chapter 41 - Flunitrazepam–Membrane Binding: A Sensor for Drug-Induced GABAA-R and Membrane Structure Changes, Pages 445-452, Anahí V. Turina, Daniel A. García, Maria A. Perillo
Chapter 42 - Neurotoxicity due to Repeated Comas Following Excessive Use of Gamma-Hydroxybutyric Acid, Pages 453-459, J.G.C. van Amsterdam, T.M. Brunt, M.T.B. McMaster, W. van den Brink
Chapter 43 - The Behavioral Effects of MDMA in Humans Under Controlled Laboratory Conditions, Pages 463-472, Matthew Kirkpatrick, Casey Guillot, Carl Hart
Chapter 44 - Recreational Use of Ecstasy (MDMA) and Hippocampal Memory: A Focus on Imaging, Pages 473-483, Christian Montag, Benjamin Becker
Chapter 45 - Catalepsy and Comparing Gamma-Hydroxybutyrate, 1,4-Butanediol, and Gamma-Butyrolactone, Pages 484-490, Siripan Phattanarudee, Timothy J. Maher, Pasarapa Towiwat
Chapter 46 - Epidemiology of Gamma-Hydroxybutyrate (GHB) Use and Misuse and Characteristics of GHB-Dependent Inpatients, Pages 491-499, T.M. Brunt, Martijn van Noorden, Rama Kamal, Boukje Dijkstra, Cor de Jong
Chapter 47 - Assays for MDMA and Its Metabolites, Pages 503-512, Bardia Jamali, Meshkat Torkamanian, Nima Badri, Behjat Sheikholeslami, Yalda Hosseinzadeh Ardakani, Mohammad-Reza Rouini
Chapter 48 - Assays for Flunitrazepam, Pages 513-528, Béla Kiss, Ede Bodoki, Anca Pop, Felicia Loghin
Chapter 49 - Detection of GHB by Optical Methods, Pages 529-535, Wang Xu, Duanting Zhai, Young-Tae Chang
Chapter 50 - Ketamine Analgesia, Pages 541-550, Linda C.J. Oudejans, Monique van Velzen, Albert Dahan
Chapter 51 - The Plant Salvia divinorum (Lamiaceae)—Chemistry and Pharmacology, Pages 551-560, Adam W. Keasling, Jordan K. Zjawiony
Chapter 52 - Pathophysiology of Ketamine Neurotoxicity: An Overview, Pages 563-572, Mustafa Aydin, Ugur Deveci
Chapter 53 - Neurometabolic Profiling of Ketamine: Changes in Neurotransmitter Pools, Pages 573-580, Antonio Napolitano, Martina Andellini
Chapter 54 - Impact of Early Life Ketamine Exposure on the Developing Brain and Cognitive Sequelae: A Discussion of Apoptotic Neurodegeneration Mechanisms, Pages 581-592, Saurabh S. Kokane, Qing Lin
Chapter 55 - Phencyclidine (Also Called Angel Dust or PCP) and the Firing Activity of Neurons, Pages 593-603, Eiichi Jodo
Chapter 56 - Phencyclidine (Angel Dust, PCP) and Fos Immunoreactivity, Pages 604-613, Hideko Yamamoto, Wakako Sawada, Etsuko Kamegaya, Yoko Hagino, Kazutaka Ikeda, Ichiro Sora, Masayoshi Mishina, Toshifumi Yamamoto
Chapter 57 - Effect of Phencyclidine on Neuregulin Expression, Cortical Interneurons, and Redox Dysregulation, Pages 614-624, Nataša Petronijević, Nevena V. Radonjić
Chapter 58 - Involvement of Glutamate Transporters in Neuropathology of Phencyclidine Abuse, Pages 625-635, Akihiro Mouri, Hirotake Hida, Yukihiro Noda
Chapter 59 - Antidepressant and Abuse Potential of Ketamine, Pages 639-648, H.W.W. Hasselmann
Chapter 60 - Ketamine and the Dissociatives: Comparisons with Schizophrenia, Pages 649-660, Joel Frohlich, John Darrell Van Horn
Chapter 61 - Ketamine Mediates Psychosis through the Medial Septum, Hippocampus, and Nucleus Accumbens, Pages 661-671, L. Stan Leung, Jingyi Ma
Chapter 62 - Recreational Use of Ketamine and Its Interaction with NMDA Receptors, Pages 672-680, Luís Félix, Luís Antunes, Sónia Campos, Carlos Venâncio, Ana Maria Coimbra
Chapter 63 - Ketamine Usage at Subanesthetic Doses and Psychoactive Effects, Pages 681-688, Daniel Flack, Elias Dakwar
Chapter 64 - The Acute and Chronic Effects of Ketamine as Revealed by Noninvasive Brain Imaging, Pages 689-702, Meng Li, Martin Walter
Chapter 65 - Psychosis Induced by Phencyclidine (Also Called PCP or Angel Dust), Pages 703-713, Tadahiro Katayama, Yoshiaki Suzuki, Eiichi Jodo
Chapter 66 - Serotonin Projections, the Dorsal and Median Raphe Nuclei, and Phencyclidine (Also Called Angel Dust or PCP), Pages 714-722, Snezana Kusljic, Wendy Adams, Maarten van den Buuse
Chapter 67 - Phencyclidine (PCP)–Induced Deficits in Novel Object Recognition, Pages 723-732, Nichole M. Neugebauer, Lakshmi Rajagopal, Mei Huang, Herbert Y. Meltzer
Chapter 68 - Behavioral and Psychological Effects of Salvia divinorum: A Focus on Self-Reported Subjective Acute Behavioral Effects and Laboratory Studies, Pages 733-738, Peter H. Addy
Chapter 69 - The Widely Available Hallucinogenic Plant Salvia divinorum and Its Main Component, Salvinorin A: A Unique κ-Opioid Receptor (KOP-r) Agonist with Powerful Behavioral and Neurobiological Effects, Pages 739-746, Eduardo R. Butelman, Mary Jeanne Kreek
Chapter 70 - Enzyme Immunoassay for Salvinorin A (a Main Component in Salvia divinorum), Pages 749-756, Hiroyuki Tanaka, Madan Kumar Paudel, Osamu Shirota, Kaori Sasaki-Tabata, Setsuko Sekita, Satoshi Morimoto
Chapter 71 - Hallucinogenic Plants in the Mediterranean Countries, Pages 761-772, Ioannis D. Passos, Maria Mironidou-Tzouveleki
Chapter 72 - Use of LSD by Mental Health Professionals, Pages 773-781, Petr Winkler, Ingmar Gorman, Rita Kočárová
Chapter 73 - Neurobiology of the Effects of Psilocybin in Relation to Its Potential Therapeutic Targets, Pages 782-793, Filip Tyls, Tomas Palenicek, Jiri Horacek
Chapter 74 - A Profile of Those Who Use Hallucinogenic Mushrooms, Pages 794-800, Mitchell G. Spring, Rory D. Ostrow, Robert M. Hallock
Chapter 75 - Molecular and Cellular Basis of Hallucinogen Action, Pages 803-812, James B. Hanks, Javier González-Maeso
Chapter 76 - Hallucinogens: Circuits, Behavior, and Translational Models, Pages 813-820, James B. Hanks, Javier González-Maeso
Chapter 77 - Hippocampal Neurogenesis: Effects of Psychedelic Drugs, Pages 821-831, Briony J. Catlow, Ahmad Jalloh, Juan Sanchez-Ramos
Chapter 78 - Lysergic Acid Diethylamide and Mystical Experiences, Pages 835-845, Michael Lyvers
Chapter 79 - Tolerance to Lysergic Acid Diethylamide: Overview, Correlates, and Clinical Implications, Pages 846-858, T. Buchborn, G. Grecksch, D.C. Dieterich, V. Höllt
Chapter 80 - Schizophrenia Modeling Using Lysergic Acid Diethylamide, Pages 859-865, Charles D. Nichols
Chapter 81 - Psilocybin and Peak Experiences, Pages 866-874, Jennifer Lyke
Chapter 82 - Psilocybin as an Inducer of Ego Death and Similar Experiences of Religious Provenance, Pages 875-889, Katarzyna Stebelska, Krzysztof Łabuz
Chapter 83 - Psilocybin, Lysergic Acid Diethylamide, Mescaline, and Drug-Induced Synesthesia, Pages 890-905, Berit Brogaard, Dimitria Electra Gatzia
Chapter 84 - Assays for Detection of Fungal Hallucinogens Such as Psilocybin and Psilocin, Pages 909-926, Katarzyna Stebelska
Chapter 85 - Inhalant Use Disorders in the United States, Pages 931-942, Scott E. Bowen, Matthew O. Howard, Eric L. Garland
Chapter 86 - The Neuropathology of Adolescent Anabolic/Androgenic Steroid Abuse: Altered Development of the Reciprocal Hypothalamic Neural Circuit Controlling Aggressive Behavior, Pages 945-957, Richard H. Melloni Jr., Thomas R. Morrison, Lesley A. Ricci
Chapter 87 - Addiction to, Neurobiology of, and Genetics of Inhalants, Pages 958-963, Rasmon Kalayasiri, Michael Maes
Chapter 88 - The Effects of Abused Inhalants on Neurons Within the Addiction Neurocircuitry of the Brain, Pages 964-978, John J. Woodward, Jacob T. Beckley
Chapter 89 - Anabolic Androgenic Steroids and Stroke, Pages 981-990, Carlos García Esperón, Elena López-Cancio M., Pablo García Bermejo, Antonio Dávalos E.
Chapter 90 - Testosterone and Striatal Dopaminergic Neurotoxicity, Pages 991-997, Dean E. Dluzen
Chapter 91 - Acute and Long-Term Toxicity Caused by Addictive Inhalation of Nitrous Oxide and Impact on Neuropathology, Pages 998-1003, Barbara Potocka-Banaś, Teresa Dembińska, Krzysztof Borowiak
Chapter 92 - Toluene Abuse and White Matter Degeneration, Pages 1004-1011, Marc R. Del Bigio
Chapter 93 - Chronic Toluene Exposure and the Hippocampal Structure in Adolescent and Adult Brains, Pages 1012-1021, Mzia Zhvania, Nadezhda Japaridze, Lela Chilachava, Lia Gelazonia, Nino Pochkhidze
Chapter 94 - Addictions in India, Pages 1025-1035, Debasish Basu, Abhishek Ghosh, Siddharth Sarkar
Chapter 95 - Correlates and Gender Differentials of Opium Use Among Tribal Communities, Pages 1036-1045, Himanshu K. Chaturvedi, Ram C. Bajpai, Arvind Pandey
Chapter 96 - Genetic Aspects of Smoking Behavior in the Japanese Population, Pages 1046-1054, Naomi Sato, Tomonori Sato, Haruhiko Sugimura
Chapter 97 - New Designer Drugs in Japan, Pages 1055-1065, Ruri Kikura-Hanajiri
Chapter 98 - Addictions in South America, Pages 1066-1074, Martin Nizama-Valladolid
Chapter 99 - Inhalant Drug Use and Street Youth: Ethnographic Insights from Mexico City∗, Pages 1075-1084, Roy Gigengack
Chapter 100 - Illegal Stimulants Use in Brazil: Epidemiological Aspects and Possible Reasons for High Consumption of Crack/Cocaine and Amphetamine-type Stimulants, Pages 1085-1093, Renata Rigacci Abdalla, Raul Caetano, Luciana Massaro, Sandro Mitsuhiro, Ilana Pinsky, Ronaldo Ramos Laranjeira, Clarice Sandi Madruga
Chapter 101 - Addiction in Thailand, Pages 1094-1100, Rasmon Kalayasiri
Chapter 102 - Misuse of Benzodiazepines in France, Pages 1101-1111, Joëlle Micallef, Elisabeth Frauger, Maryse Lapeyre-Mestre
Index, Pages 1113-1143